Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01099 SINOPHARM
RTNominal down20.900 -0.100 (-0.476%)
Others

21/11/2017 12:07

Sinopharm (01099) names Liu Yong as new president

[ET Net News Agency, 21 November 2017] Sinopharm Group (01099) said Li Zhiming proposed
to cease to serve as the president today due to change in responsibilities and Li
continues to serve as the chairman of the Board and the secretary of Party Committee of
the company.
Liu Yong has been appointed as the president with immediate effect and nominated as an
executive director of the fourth session of the Board and a member of the strategy and
investment committee under the Board. Due to the above-mentioned work adjustment, Liu
ceased to serve as vice president and secretary to the Board today. (HL)

Remark: Real time quote last updated: 23/04/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.